The President wants to present us with a false choice between legislating and investigating. Well we're not going to accept that deal.

I've told Ms. Weichert that one of the things that I've been always concerned about is people having career opportunities.

I want to commend Chairman Connolly for today's hearing. He has always been one who has consistently been at the forefront of making sure that our Federal employees are protected.

Although we may disagree on some things, we are never disagreeable.

I simply ask that these drugs be reasonably priced so that those most marginalized and at risk can reap their benefit.

In order to do that, we have to continue to invest in research for the patent life of our medicines.

We want to be effective and efficient. Is there any agency that can identify who these people are that need this treatment?

I want to recognize the efforts of our distinguished colleague, Congresswoman Ocasio-Cortez.

I believe that there are actions that you could take, that this committee could take at this time that would make PrEP available.

So that cuts into your profit. Is that what you are saying?

I can't resist asking you a question, Mr. O'Day. Instead of the donations you are offering, even some of the reductions, why not simply lower the price of PrEP?

We were trying to solve a gap that isn't currently covered by our current access programs.

They know the cure is out there. They know there is something out there called Truvada.

One of my first employees died from AIDS, and I will never forget it.

I want to thank you for your leadership.

Nobody is coming here to beat you up. I want to make that clear.

I have no problem with you all making a profit. I want you to make a profit.

At the end of the day, it is the taxpayers who bear the cost of these skyrocketing prices through government programs like Medicaid.

I have applauded Gilead for their research and what they have been able to accomplish.

I think you testified that your company earned $36 billion in revenue, and you are telling me that at that rate of revenue, we just wouldn't have PrEP at all?

I think the committee on both sides have asked reasonable questions.

Think about this: We now have a drug that has the potential to end the HIV epidemic.

For $333 a month, a 22-year-old college graduate died.

I have heard a lot of talk here this morning about how people are beaten up--it is not about beating up. It is about being thankful that we have a medication that can do just about everything but finally cure it, AIDS, and wanting it to…

We want to understand why the price is so high, and we are trying to understand how we can get the 90 percent of people who need this lifesaving medication, how we can get it to them.